| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Ablation of collagen VI leads to the release of platelets with altered function
|
Abbonante, Vittorio
|
|
|
|
23 |
p. 5150-5163
|
artikel
|
| 2 |
Ablation of miR-146b in mice causes hematopoietic malignancy
|
Mitsumura, Takahiro
|
|
|
|
23 |
p. 3483-3491
|
artikel
|
| 3 |
A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers
|
Lee, LaTasha H.
|
|
|
|
23 |
p. 5323-5331
|
artikel
|
| 4 |
Acquired CD38 gene deletion as a mechanism of tumor antigen escape in multiple myeloma
|
Portuguese, Andrew J.
|
|
|
|
23 |
p. 7235-7238
|
artikel
|
| 5 |
Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group
|
Chisholm, Karen M.
|
|
|
|
23 |
p. 6000-6008
|
artikel
|
| 6 |
Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma
|
Gebauer, Niklas
|
|
|
|
23 |
p. 5220-5225
|
artikel
|
| 7 |
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells
|
Eriksson, Mia
|
|
|
|
23 |
p. 2046-2057
|
artikel
|
| 8 |
A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN
|
Xiao, Wenbin
|
|
|
|
23 |
p. 6034-6038
|
artikel
|
| 9 |
A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma
|
Munshi, Nikhil C.
|
|
|
|
23 |
p. 5988-5999
|
artikel
|
| 10 |
ALCAM-EGFR interaction regulates myelomagenesis
|
Luo, Hongmei
|
|
|
|
23 |
p. 5269-5282
|
artikel
|
| 11 |
ALL blasts drive primary mesenchymal stromal cells to increase asparagine availability during asparaginase treatment
|
Chiu, Martina
|
|
|
|
23 |
p. 5164-5178
|
artikel
|
| 12 |
American Society of Hematology 2019 guidelines for immune thrombocytopenia
|
Neunert, Cindy
|
|
|
|
23 |
p. 3829-3866
|
artikel
|
| 13 |
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients
|
Anderson, David R.
|
|
|
|
23 |
p. 3898-3944
|
artikel
|
| 14 |
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease
|
Liem, Robert I.
|
|
|
|
23 |
p. 3867-3897
|
artikel
|
| 15 |
Amplification and overexpression of E2 ubiquitin conjugase UBE2T promotes homologous recombination in multiple myeloma
|
Alagpulinsa, David A.
|
|
|
|
23 |
p. 3968-3972
|
artikel
|
| 16 |
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease
|
Hankins, Jane S.
|
|
|
|
23 |
p. 7190-7201
|
artikel
|
| 17 |
An autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodies
|
Roider, Tobias
|
|
|
|
23 |
p. 5060-5071
|
artikel
|
| 18 |
Another step toward frontline BTK inhibitor therapy in MCL
|
Hanel, Walter
|
|
|
|
23 |
p. 7358-7360
|
artikel
|
| 19 |
A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival
|
Lamaison, Claire
|
|
|
|
23 |
p. 5372-5386
|
artikel
|
| 20 |
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation
|
Li, Li
|
|
|
|
23 |
p. 4117-4130
|
artikel
|
| 21 |
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma
|
Herrera, Alex F.
|
|
|
|
23 |
p. 5300-5311
|
artikel
|
| 22 |
Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F–induced disease
|
Müller, Peter
|
|
|
|
23 |
p. 5349-5359
|
artikel
|
| 23 |
Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects
|
Eckardt, Jan-Niklas
|
|
|
|
23 |
p. 6077-6085
|
artikel
|
| 24 |
ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology
|
Wood, William A.
|
|
|
|
23 |
p. 5429-5438
|
artikel
|
| 25 |
A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions
|
Kim, Sojeong
|
|
|
|
23 |
p. 6093-6107
|
artikel
|
| 26 |
Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registry
|
Bowers, Charles
|
|
|
|
23 |
p. 4969-4979
|
artikel
|
| 27 |
Association between congenital thrombophilia and outcomes in pulmonary embolism patients
|
Lian, Tian-Yu
|
|
|
|
23 |
p. 5958-5965
|
artikel
|
| 28 |
Association of race and ethnicity with clinical phenotype, genetics, and survival in pediatric acute myeloid leukemia
|
Conneely, Shannon E.
|
|
|
|
23 |
p. 4992-5001
|
artikel
|
| 29 |
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma
|
Thieblemont, Catherine
|
|
|
|
23 |
p. 5995-6004
|
artikel
|
| 30 |
AVEXIS technology identifies novel platelet-leukocyte binding partners including CD148-CD300a
|
Barroso, Ruben
|
|
|
|
23 |
p. 5016-5019
|
artikel
|
| 31 |
Ayuk FA, Berger C, Badbaran A, et al. Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting. Blood Adv. 2021;5(11):2523-2527.
|
|
|
|
|
23 |
p. 6075
|
artikel
|
| 32 |
Bleeding assessment tools in the diagnosis of VWD in adults and children: a systematic review and meta-analysis of test accuracy
|
Kalot, Mohamad A.
|
|
|
|
23 |
p. 5023-5031
|
artikel
|
| 33 |
Bone marrow remodeling supports hematopoiesis in response to immune thrombocytopenia progression in mice
|
Herd, Oliver J.
|
|
|
|
23 |
p. 4877-4889
|
artikel
|
| 34 |
Bye AP, Unsworth AJ, Desborough MJ, et al. Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib. Blood Adv. 2017;1(26):2610-2623.
|
|
|
|
|
23 |
p. 3515
|
artikel
|
| 35 |
Cadherin 17 mutation associated with leaky severe combined immune deficiency is corrected by HSCT
|
Smith, Angela R.
|
|
|
|
23 |
p. 2083-2087
|
artikel
|
| 36 |
CapTCR-seq: hybrid capture for T-cell receptor repertoire profiling
|
Mulder, David T.
|
|
|
|
23 |
p. 3506-3514
|
artikel
|
| 37 |
Carfilzomib-induced aHUS responds to early eculizumab and may be associated with heterozygous CFHR3-CFHR1 deletion
|
Portuguese, Andrew Jay
|
|
|
|
23 |
p. 3443-3446
|
artikel
|
| 38 |
CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes
|
Huang, Benjamin J.
|
|
|
|
23 |
p. 4963-4968
|
artikel
|
| 39 |
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
|
Ghandili, Susanne
|
|
|
|
23 |
p. 5936-5941
|
artikel
|
| 40 |
Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization
|
Teierle, Samantha M.
|
|
|
|
23 |
p. 7239-7242
|
artikel
|
| 41 |
C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
|
Shah, Hridaya
|
|
|
|
23 |
p. 6071-6074
|
artikel
|
| 42 |
Cleavage of talin by calpain promotes platelet-mediated fibrin clot contraction
|
Fong, Karen P.
|
|
|
|
23 |
p. 4901-4909
|
artikel
|
| 43 |
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia
|
Tiong, Ing S.
|
|
|
|
23 |
p. 5107-5111
|
artikel
|
| 44 |
Combined ibrutinib and venetoclax treatment vs single agents in the TCL1 mouse model of chronic lymphocytic leukemia
|
Kater, Arnon P.
|
|
|
|
23 |
p. 5410-5414
|
artikel
|
| 45 |
Computational analysis of continuous body temperature provides early discrimination of graft-versus-host disease in mice
|
He, Kuang
|
|
|
|
23 |
p. 3977-3981
|
artikel
|
| 46 |
COVID-19 in patients with classic and variant hairy cell leukemia
|
Kreitman, Robert J.
|
|
|
|
23 |
p. 7161-7168
|
artikel
|
| 47 |
Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL
|
O’Connor, David
|
|
|
|
23 |
p. 7231-7234
|
artikel
|
| 48 |
CXCL12-abundant reticular cells are the major source of IL-6 upon LPS stimulation and thereby regulate hematopoiesis
|
Gerosa, Rahel C.
|
|
|
|
23 |
p. 5002-5015
|
artikel
|
| 49 |
Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura
|
Cataland, Spero R.
|
|
|
|
23 |
p. 2075-2082
|
artikel
|
| 50 |
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study
|
Palareti, Gualtiero
|
|
|
|
23 |
p. 6005-6015
|
artikel
|
| 51 |
Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency
|
Perez, Monika W.
|
|
|
|
23 |
p. 4864-4876
|
artikel
|
| 52 |
Depression, quality of life, and medical resource utilization in sickle cell disease
|
Adam, Soheir S.
|
|
|
|
23 |
p. 1983-1992
|
artikel
|
| 53 |
Differential sialic acid content in adult and neonatal fibrinogen mediates differences in clot polymerization dynamics
|
Nellenbach, Kimberly
|
|
|
|
23 |
p. 5202-5214
|
artikel
|
| 54 |
Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis
|
Wenk, Catharina
|
|
|
|
23 |
p. 3447-3461
|
artikel
|
| 55 |
Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia
|
Li, Zhenhua
|
|
|
|
23 |
p. 5226-5238
|
artikel
|
| 56 |
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
|
Spasevska, Ivana
|
|
|
|
23 |
p. 7216-7230
|
artikel
|
| 57 |
Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activity
|
Suraneni, Praveen K.
|
|
|
|
23 |
p. 3540-3552
|
artikel
|
| 58 |
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
|
Lambert, Juliette
|
|
|
|
23 |
p. 5258-5268
|
artikel
|
| 59 |
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
|
Bond, David A.
|
|
|
|
23 |
p. 5179-5189
|
artikel
|
| 60 |
Early response markers predict survival after etoposide-based therapy of hemophagocytic lymphohistiocytosis
|
Verkamp, Bethany
|
|
|
|
23 |
p. 7258-7269
|
artikel
|
| 61 |
E-cadherin/β-catenin expression is conserved in human and rat erythropoiesis and marks stress erythropoiesis
|
Krimpenfort, Rosa A.
|
|
|
|
23 |
p. 7169-7183
|
artikel
|
| 62 |
Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial
|
Hsu, Peter
|
|
|
|
23 |
p. 5032-5040
|
artikel
|
| 63 |
Editorial Board
|
|
|
|
|
23 |
p. i
|
artikel
|
| 64 |
Editorial Board
|
|
|
|
|
23 |
p. i
|
artikel
|
| 65 |
Editorial Board
|
|
|
|
|
23 |
p. i
|
artikel
|
| 66 |
Editorial Board
|
|
|
|
|
23 |
p. i
|
artikel
|
| 67 |
Editorial Board
|
|
|
|
|
23 |
p. i
|
artikel
|
| 68 |
Editorial Board
|
|
|
|
|
23 |
p. i
|
artikel
|
| 69 |
Editorial Board
|
|
|
|
|
23 |
p. i
|
artikel
|
| 70 |
Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma
|
Casneuf, Tineke
|
|
|
|
23 |
p. 2105-2114
|
artikel
|
| 71 |
Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma
|
Frerichs, Kristine A.
|
|
|
|
23 |
p. 5128-5139
|
artikel
|
| 72 |
End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain
|
Farrell, Ann T.
|
|
|
|
23 |
p. 3982-4001
|
artikel
|
| 73 |
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings
|
Farrell, Ann T.
|
|
|
|
23 |
p. 4002-4020
|
artikel
|
| 74 |
Engraftment characterization of risk-stratified AML in NSGS mice
|
Díaz de la Guardia, Rafael
|
|
|
|
23 |
p. 4842-4854
|
artikel
|
| 75 |
Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors
|
Meliani, Amine
|
|
|
|
23 |
p. 2019-2031
|
artikel
|
| 76 |
Evaluating the prevalence of inborn errors of immunity in adults with chronic immune thrombocytopenia or Evans syndrome
|
Jiang, Debbie
|
|
|
|
23 |
p. 7202-7208
|
artikel
|
| 77 |
Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations
|
Diorio, Caroline
|
|
|
|
23 |
p. 6051-6063
|
artikel
|
| 78 |
Field JJ, Majerus E, Gordeuk VR, et al. Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease. Blood Adv. 2017;1(20):1645-1649.
|
|
|
|
|
23 |
p. 2058
|
artikel
|
| 79 |
Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage
|
Leich, Ellen
|
|
|
|
23 |
p. 4890-4900
|
artikel
|
| 80 |
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma
|
Pighi, Chiara
|
|
|
|
23 |
p. 5239-5257
|
artikel
|
| 81 |
Front Matter
|
|
|
|
|
23 |
p. ii
|
artikel
|
| 82 |
Front Matter
|
|
|
|
|
23 |
p. ii
|
artikel
|
| 83 |
GATA1 controls numbers of hematopoietic progenitors and their response to autoimmune neuroinflammation
|
Hwang, Daniel
|
|
|
|
23 |
p. 5980-5994
|
artikel
|
| 84 |
GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells
|
Jung, Moonjung
|
|
|
|
23 |
p. 3553-3565
|
artikel
|
| 85 |
GDP/GTP exchange factor MADD drives activation and recruitment of secretory Rab GTPases to Weibel-Palade bodies
|
Kat, Marije
|
|
|
|
23 |
p. 5116-5127
|
artikel
|
| 86 |
Genome-wide whole-blood transcriptome profiling across inherited bone marrow failure subtypes
|
Walne, Amanda J.
|
|
|
|
23 |
p. 5360-5371
|
artikel
|
| 87 |
Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion
|
Wienand, Kirsty
|
|
|
|
23 |
p. 4065-4080
|
artikel
|
| 88 |
Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
|
McCall, David
|
|
|
|
23 |
p. 5215-5219
|
artikel
|
| 89 |
Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia
|
Zavorka Thomas, Megan E.
|
|
|
|
23 |
p. 5041-5046
|
artikel
|
| 90 |
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya
|
Uyoga, Sophie
|
|
|
|
23 |
p. 5942-5950
|
artikel
|
| 91 |
Hapln1b, a central organizer of the ECM, modulates kit signaling to control developmental hematopoiesis in zebrafish
|
Mahony, Christopher B.
|
|
|
|
23 |
p. 4935-4948
|
artikel
|
| 92 |
Health-related quality of life with lisocabtagene maraleucel vs standard of care in relapsed or refractory LBCL
|
Abramson, Jeremy S.
|
|
|
|
23 |
p. 5969-5979
|
artikel
|
| 93 |
Hematopoietic stem cell transplant for Hurler syndrome: does using bone marrow or umbilical cord blood make a difference?
|
Orchard, Paul J.
|
|
|
|
23 |
p. 6023-6027
|
artikel
|
| 94 |
HGAL inhibits lymphoma dissemination by interacting with multiple cytoskeletal proteins
|
Jiang, Xiaoyu
|
|
|
|
23 |
p. 5072-5085
|
artikel
|
| 95 |
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma
|
Camus, Vincent
|
|
|
|
23 |
p. 7331-7345
|
artikel
|
| 96 |
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
|
Barker, Juliet N.
|
|
|
|
23 |
p. 6064-6076
|
artikel
|
| 97 |
Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type
|
Emile, Jean-François
|
|
|
|
23 |
p. 7254-7257
|
artikel
|
| 98 |
HSC extrinsic sex-related and intrinsic autoimmune disease–related human B-cell variation is recapitulated in humanized mice
|
Borsotti, Chiara
|
|
|
|
23 |
p. 2007-2018
|
artikel
|
| 99 |
Human iPSC-derived macrophages for efficient Staphylococcus aureus clearance in a murine pulmonary infection model
|
Rafiei Hashtchin, Anna
|
|
|
|
23 |
p. 5190-5201
|
artikel
|
| 100 |
Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma
|
Wang, Ying
|
|
|
|
23 |
p. 5290-5299
|
artikel
|
| 101 |
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma
|
Karmali, Reem
|
|
|
|
23 |
p. 7361-7368
|
artikel
|
| 102 |
Identification and characterization of RBM12 as a novel regulator of fetal hemoglobin expression
|
Wakabayashi, Aoi
|
|
|
|
23 |
p. 5956-5968
|
artikel
|
| 103 |
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
|
Syrykh, Charlotte
|
|
|
|
23 |
p. 7384-7391
|
artikel
|
| 104 |
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
|
Maurer, Katie
|
|
|
|
23 |
p. 5140-5149
|
artikel
|
| 105 |
Impact of last lenalidomide dose, duration, and IMiD-free interval in patients with myeloma treated with pomalidomide/dexamethasone
|
Kastritis, Efstathios
|
|
|
|
23 |
p. 4095-4103
|
artikel
|
| 106 |
In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported
|
Anekpuritanang, Tauangtham
|
|
|
|
23 |
p. 5057-5059
|
artikel
|
| 107 |
Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia
|
Verneris, Michael R.
|
|
|
|
23 |
p. 5387-5395
|
artikel
|
| 108 |
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days
|
Mikkilineni, Lekha
|
|
|
|
23 |
p. 5312-5322
|
artikel
|
| 109 |
Inhibition of NADPH oxidase blocks NETosis and reduces thrombosis in heparin-induced thrombocytopenia
|
Leung, Halina H.L.
|
|
|
|
23 |
p. 5439-5451
|
artikel
|
| 110 |
Inhibition of the mutated c-KIT kinase in AML1-ETO–positive leukemia cells restores sensitivity to PARP inhibitor
|
Nieborowska-Skorska, Margaret
|
|
|
|
23 |
p. 4050-4054
|
artikel
|
| 111 |
Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies
|
Davids, Matthew S.
|
|
|
|
23 |
p. 5332-5343
|
artikel
|
| 112 |
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease
|
van Rhee, Frits
|
|
|
|
23 |
p. 6039-6050
|
artikel
|
| 113 |
Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents
|
Aldoss, Ibrahim
|
|
|
|
23 |
p. 4043-4049
|
artikel
|
| 114 |
Investigational curative gene therapy approaches to sickle cell disease
|
Williams, David A.
|
|
|
|
23 |
p. 5452
|
artikel
|
| 115 |
Is donor-recipient sex associated with transfusion-related outcomes in critically ill patients?
|
Wood, Henry
|
|
|
|
23 |
p. 6076-6077
|
artikel
|
| 116 |
JAK2V617F and ischemic stroke: CHIP or CMD-NBV?
|
Barosi, Giovanni
|
|
|
|
23 |
p. 7329-7330
|
artikel
|
| 117 |
Large-scale circular RNA deregulation in T-ALL: unlocking unique ectopic expression of molecular subtypes
|
Buratin, Alessia
|
|
|
|
23 |
p. 5902-5914
|
artikel
|
| 118 |
Leukocytosis and thrombosis in polycythemia vera: can clinical trials settle the debate?
|
Barbui, Tiziano
|
|
|
|
23 |
p. 3951-3952
|
artikel
|
| 119 |
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant
|
Chihara, Dai
|
|
|
|
23 |
p. 4807-4816
|
artikel
|
| 120 |
Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy
|
Voorhees, Timothy J.
|
|
|
|
23 |
p. 5925-5928
|
artikel
|
| 121 |
Loss of early myeloid donor cell engraftment into the central nervous system with nonmyeloablative conditioning
|
Nolan, Erin E.
|
|
|
|
23 |
p. 7290-7294
|
artikel
|
| 122 |
Loss of GSK3β in hematopoietic stem cells results in normal hematopoiesis in mice
|
Lee, Grace
|
|
|
|
23 |
p. 7185-7189
|
artikel
|
| 123 |
Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma
|
Kennedy, Vanessa E.
|
|
|
|
23 |
p. 5344-5348
|
artikel
|
| 124 |
Macrophages and osteoclasts stem from a bipotent progenitor downstream of a macrophage/osteoclast/dendritic cell progenitor
|
Xiao, Yanling
|
|
|
|
23 |
p. 1993-2006
|
artikel
|
| 125 |
Measles virus envelope pseudotyped lentiviral vectors transduce quiescent human HSCs at an efficiency without precedent
|
Lévy, Camille
|
|
|
|
23 |
p. 2088-2104
|
artikel
|
| 126 |
Metabolic abnormalities in G6PC3-deficient human neutrophils result in severe functional defects
|
McKinney, Christopher
|
|
|
|
23 |
p. 5888-5901
|
artikel
|
| 127 |
Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A
|
Agosti, Pasquale
|
|
|
|
23 |
p. 7209-7215
|
artikel
|
| 128 |
Molecular features of a large cohort of primary central nervous system lymphoma using tissue microarray
|
Villa, Diego
|
|
|
|
23 |
p. 3953-3961
|
artikel
|
| 129 |
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms
|
Durham, Benjamin H.
|
|
|
|
23 |
p. 7319-7328
|
artikel
|
| 130 |
NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease
|
De Ravin, Suk See
|
|
|
|
23 |
p. 5976-5987
|
artikel
|
| 131 |
Narkhede M, Goyal G, Shea L, et al. Evaluating real-world treatment patterns and outcomes of mantle cell lymphoma. Blood Adv. 2022; 6(14):4122-4131.
|
|
|
|
|
23 |
p. 6039
|
artikel
|
| 132 |
Neurocognitive impairment associated with chronic morbidity in long-term survivors of Hodgkin Lymphoma
|
Phillips, Nicholas S.
|
|
|
|
23 |
p. 7270-7278
|
artikel
|
| 133 |
Nfe2 is dispensable for early but required for adult thrombocyte formation and function in zebrafish
|
Rost, Megan S.
|
|
|
|
23 |
p. 3418-3427
|
artikel
|
| 134 |
NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia
|
Yoshida, Masanori
|
|
|
|
23 |
p. 5420-5428
|
artikel
|
| 135 |
Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?
|
Goldmann, Luise
|
|
|
|
23 |
p. 4021-4033
|
artikel
|
| 136 |
Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience
|
Richard-Carpentier, Guillaume
|
|
|
|
23 |
p. 5415-5419
|
artikel
|
| 137 |
Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
|
Wood, William A.
|
|
|
|
23 |
p. 5966-5975
|
artikel
|
| 138 |
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
|
Desai, Sanjal H.
|
|
|
|
23 |
p. 7295-7303
|
artikel
|
| 139 |
Pacritinib demonstrates spleen volume reduction in patients with myelofibrosis independent of JAK2V617F allele burden
|
Tremblay, Douglas
|
|
|
|
23 |
p. 5929-5935
|
artikel
|
| 140 |
Patients with FLT3-mutant AML needed to enroll on FLT3-targeted therapeutic clinical trials
|
Bucy, Taylor
|
|
|
|
23 |
p. 4055-4064
|
artikel
|
| 141 |
Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant
|
Lin, Andrew
|
|
|
|
23 |
p. 7153-7160
|
artikel
|
| 142 |
PD-1 inhibition in advanced myeloproliferative neoplasms
|
Hobbs, Gabriela
|
|
|
|
23 |
p. 5086-5097
|
artikel
|
| 143 |
PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation
|
Xiao, Wenbin
|
|
|
|
23 |
p. 3526-3539
|
artikel
|
| 144 |
Pirillo C, Birch F, Tissot FS, et al. Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness. Blood Adv. 2022;6(10):3126-3141.
|
|
|
|
|
23 |
p. 7184
|
artikel
|
| 145 |
Platelet FcγRIIA-induced serotonin release exacerbates the severity of transfusion-related acute lung injury in mice
|
El Mdawar, Marie-Belle
|
|
|
|
23 |
p. 4817-4830
|
artikel
|
| 146 |
Potential impact of complement regulator deficiencies on hemolytic reactions due to minor ABO-mismatched transfusions
|
Pandey, Priyanka
|
|
|
|
23 |
p. 1977-1982
|
artikel
|
| 147 |
Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation
|
Ren, Xiying
|
|
|
|
23 |
p. 4910-4921
|
artikel
|
| 148 |
Preferences for potential benefits and risks for gene therapy in the treatment of sickle cell disease
|
Gonzalez Sepulveda, Juan Marcos
|
|
|
|
23 |
p. 7371-7381
|
artikel
|
| 149 |
Pregnancy-related venous thromboembolism and risk of occult cancer
|
Hansen, Anette Tarp
|
|
|
|
23 |
p. 2059-2062
|
artikel
|
| 150 |
p53 regulates CD46 expression and measles virus infection in myeloma cells
|
Lok, Anne
|
|
|
|
23 |
p. 3492-3505
|
artikel
|
| 151 |
Production and nonclinical evaluation of an autologous iPSC–derived platelet product for the iPLAT1 clinical trial
|
Sugimoto, Naoshi
|
|
|
|
23 |
p. 6056-6069
|
artikel
|
| 152 |
Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review
|
Neil, Elizabeth C.
|
|
|
|
23 |
p. 2041-2045
|
artikel
|
| 153 |
Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial
|
Moccia, Alden A.
|
|
|
|
23 |
p. 5951-5957
|
artikel
|
| 154 |
PTCy ameliorates GVHD by restoring regulatory and effector T-cell homeostasis in recipients with PD-1 blockade
|
Ikegawa, Shuntaro
|
|
|
|
23 |
p. 4081-4094
|
artikel
|
| 155 |
PUM1 mediates the posttranscriptional regulation of human fetal hemoglobin
|
Elagooz, Reem
|
|
|
|
23 |
p. 6016-6022
|
artikel
|
| 156 |
Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma
|
Misiewicz-Krzeminska, Irena
|
|
|
|
23 |
p. 6023-6033
|
artikel
|
| 157 |
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
|
Horwitz, Steven M.
|
|
|
|
23 |
p. 5098-5106
|
artikel
|
| 158 |
Recurrent switch 2 domain RAC2 mutations in intravascular large B-cell lymphoma
|
Kodgule, Rohan
|
|
|
|
23 |
p. 6051-6055
|
artikel
|
| 159 |
Redundant mechanisms driven independently by RUNX1 and GATA2 for hematopoietic development
|
Bresciani, Erica
|
|
|
|
23 |
p. 4949-4962
|
artikel
|
| 160 |
Regulatory association of long noncoding RNAs and chromatin accessibility facilitates erythroid differentiation
|
Ren, Yunxiao
|
|
|
|
23 |
p. 5396-5409
|
artikel
|
| 161 |
Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib
|
Goldsmith, Scott R.
|
|
|
|
23 |
p. 4131-4135
|
artikel
|
| 162 |
Restriction of HIV-1 infection in sickle cell trait
|
Kumari, Namita
|
|
|
|
23 |
p. 4922-4934
|
artikel
|
| 163 |
Risk and timing of cardiovascular death among patients with myelodysplastic syndromes
|
Brunner, Andrew M.
|
|
|
|
23 |
p. 2032-2040
|
artikel
|
| 164 |
Robust adaptive immune response against Babesia microti infection marked by low parasitemia in a murine model of sickle cell disease
|
Yi, Woelsung
|
|
|
|
23 |
p. 3462-3478
|
artikel
|
| 165 |
Role of calcium in regulating the intra- and extracellular cleavage of von Willebrand factor by the protease ADAMTS13
|
Gogia, Shobhit
|
|
|
|
23 |
p. 2063-2074
|
artikel
|
| 166 |
RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS
|
Huang, Yi-Jou
|
|
|
|
23 |
p. 6078-6092
|
artikel
|
| 167 |
Runx1-R188Q germ line mutation induces inflammation and predisposition to hematologic malignancies in mice
|
Ahmad, Mohd Hafiz
|
|
|
|
23 |
p. 7304-7318
|
artikel
|
| 168 |
Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy
|
Jhaveri, Khushali S.
|
|
|
|
23 |
p. 6019-6022
|
artikel
|
| 169 |
Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCL
|
Miller, Jemima H.
|
|
|
|
23 |
p. 5112-5115
|
artikel
|
| 170 |
2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations
|
Murad, M. Hassan
|
|
|
|
23 |
p. 3945-3950
|
artikel
|
| 171 |
Smooth muscle cytochrome b5 reductase 3 deficiency accelerates pulmonary hypertension development in sickle cell mice
|
Wood, Katherine C.
|
|
|
|
23 |
p. 4104-4116
|
artikel
|
| 172 |
Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis
|
Fanikos, John
|
|
|
|
23 |
p. 5283-5289
|
artikel
|
| 173 |
Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias
|
Sridharan, Ashwin
|
|
|
|
23 |
p. 3962-3967
|
artikel
|
| 174 |
Stroke and myocardial infarction in hereditary thrombotic thrombocytopenic purpura: similarities to sickle cell anemia
|
Borogovac, Azra
|
|
|
|
23 |
p. 3973-3976
|
artikel
|
| 175 |
Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion
|
Ebraheem, Mohammad S.
|
|
|
|
23 |
p. 5020-5022
|
artikel
|
| 176 |
Temporal in vivo platelet labeling in mice reveals age-dependent receptor expression and conservation of specific mRNAs
|
Armstrong, Paul C.
|
|
|
|
23 |
p. 6028-6038
|
artikel
|
| 177 |
The challenge of eliciting opinions of gene therapy for SCD
|
Limerick, Emily M.
|
|
|
|
23 |
p. 7369-7370
|
artikel
|
| 178 |
The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing
|
Maierhofer, Anna
|
|
|
|
23 |
p. 7346-7357
|
artikel
|
| 179 |
The immunometabolite itaconate inhibits heme synthesis and remodels cellular metabolism in erythroid precursors
|
Marcero, Jason R.
|
|
|
|
23 |
p. 4831-4841
|
artikel
|
| 180 |
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes
|
Faruqi, Aiman J.
|
|
|
|
23 |
p. 6040-6050
|
artikel
|
| 181 |
The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy
|
Liu, Suhu
|
|
|
|
23 |
p. 3428-3442
|
artikel
|
| 182 |
The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study
|
Hijiya, Nobuko
|
|
|
|
23 |
p. 7279-7289
|
artikel
|
| 183 |
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
|
Srinagesh, Hrishikesh K.
|
|
|
|
23 |
p. 4034-4042
|
artikel
|
| 184 |
The SMAC mimetic LCL-161 displays antitumor activity in preclinical models of rituximab-resistant B-cell lymphoma
|
Runckel, Kyle
|
|
|
|
23 |
p. 3516-3525
|
artikel
|
| 185 |
Time to include IGLV3-21R110 status in CLL prognostication?
|
Rosenquist, Richard
|
|
|
|
23 |
p. 7382-7383
|
artikel
|
| 186 |
Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma
|
Thudium Mueller, Karen
|
|
|
|
23 |
p. 4980-4991
|
artikel
|
| 187 |
TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era
|
Landsburg, Daniel J.
|
|
|
|
23 |
p. 7243-7253
|
artikel
|
| 188 |
Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma
|
Wang, Chia-Ching
|
|
|
|
23 |
p. 3479-3482
|
artikel
|
| 189 |
Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel
|
Pavlovsky, Carolina
|
|
|
|
23 |
p. 4855-4863
|
artikel
|
| 190 |
Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
|
Magenau, John M.
|
|
|
|
23 |
p. 5047-5056
|
artikel
|
| 191 |
Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19
|
Ripoll, Juan G.
|
|
|
|
23 |
p. 5951-5955
|
artikel
|
| 192 |
Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
|
Chen, Yi-Bin
|
|
|
|
23 |
p. 4136-4146
|
artikel
|
| 193 |
Yes, donor-recipient sex is associated with transfusion-related outcomes in critically ill patients
|
Alshalani, Abdulrahman
|
|
|
|
23 |
p. 6070
|
artikel
|
| 194 |
Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial
|
Dimopoulos, Meletios
|
|
|
|
23 |
p. 6009-6018
|
artikel
|
| 195 |
Zebrafish Kit ligands cooperate with erythropoietin to promote erythroid cell expansion
|
Oltova, Jana
|
|
|
|
23 |
p. 5915-5924
|
artikel
|
Tijdschrift beschrijving